Chemoinformaics analysis of 17-HEPTADECANOLIDE
| Molecular Weight | 268.441 | nRot | 0 |
| Heavy Atom Molecular Weight | 236.185 | nRig | 19 |
| Exact Molecular Weight | 268.24 | nRing | 1 |
| Solubility: LogS | -6.609 | nHRing | 1 |
| Solubility: LogP | 7.003 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 51.3314 |
| nHD | 0 | BPOL | 34.7066 |
| QED | 0.55 |
| Synth | 2.286 |
| Natural Product Likeliness | 0.426 |
| NR-PPAR-gamma | 0.145 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.945 |
| MDCK | 0.0000213 |
| BBB | 0.197 |
| PPB | 0.97092 |
| VDSS | 1.821 |
| FU | 0.0151311 |
| CYP1A2-inh | 0.618 |
| CYP1A2-sub | 0.181 |
| CYP2c19-inh | 0.49 |
| CYP2c19-sub | 0.056 |
| CYP2c9-inh | 0.185 |
| CYP2c9-sub | 0.922 |
| CYP2d6-inh | 0.103 |
| CYP2d6-sub | 0.067 |
| CYP3a4-inh | 0.314 |
| CYP3a4-sub | 0.06 |
| CL | 5.227 |
| T12 | 0.261 |
| hERG | 0.313 |
| Ames | 0.01 |
| ROA | 0.034 |
| SkinSen | 0.963 |
| Carcinogencity | 0.116 |
| EI | 0.978 |
| Respiratory | 0.902 |
| NR-Aromatase | 0.115 |
| Antiviral | Yes |
| Prediction | 0.626856 |